Original language | English (US) |
---|---|
Pages (from-to) | 994-996 |
Number of pages | 3 |
Journal | JACC: Cardiovascular Imaging |
Volume | 17 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2024 |
Funding
The VALOR-HCM study was funded by Bristol Myers Squibb. The Cleveland Clinic Center for Clinical (C5) Research received funding for the trial, but none of the C5 Research personnel received any honoraria from the sponsor. Dr Desai serves as a consultant for MyoKardia (now MyoKardia Inc, a wholly owned subsidiary of Bristol Myers Squibb) and Medtronic. Drs Geske, Owens, Saberi, and Naidu serve as consultants for Bristol Myers Squibb and Cytokinetics. Dr Wang serves as a consultant for Bristol Myers Squibb and Cytokinetics; is on the speakers bureau for Bristol Myers Squibb; and has received research grants from Bristol Myers Squibb and Cytokinetics. Dr Smedia serves as a consultant for Bristol Myers Squibb. Drs Lampl and Sehnert are employees of MyoKardia Inc, a wholly owned subsidiary of Bristol Myers Squibb; and Dr Sehnert discloses Bristol Myers Squibb stock and stock grants.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine